PharmaCorp Rx Inc. (TSXV:PCRX)

Canada flag Canada · Delayed Price · Currency is CAD
0.5100
0.00 (0.00%)
At close: Jun 1, 2026
Market Cap88.78M +57.2%
Revenue (ttm)20.89M +260.6%
Net Income-1.48M
EPS-0.01
Shares Out 174.08M
PE Ration/a
Forward PE51.00
Dividendn/a
Ex-Dividend Daten/a
Volume26,241
Open0.5300
Previous Close0.5100
Day's Range0.5000 - 0.5300
52-Week Range0.4000 - 0.5800
Beta-4.30
Analystsn/a
Price Targetn/a
Earnings DateJun 3, 2026

About PharmaCorp Rx

PharmaCorp Rx Inc. operates retail pharmacies under the PharmaChoice name in Canada. The company offers prescription services; front-of-store retail, such as convenience goods, over-the-counter medications, health products, and wellness items; custom compounding; specialized consultations; and lifestyle programs. PharmaCorp Rx Inc. was incorporated in 2021 and is headquartered in Saskatoon, Canada. [Read more]

Sector Healthcare
Founded 2021
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol PCRX
Full Company Profile

Financial Performance

In 2025, PharmaCorp Rx's revenue was 20.89 million, an increase of 260.57% compared to the previous year's 5.79 million. Losses were -1.48 million, 46.3% more than in 2024.

Financial Statements

News

PharmaCorp Rx Registration statement: Q1 2026

PharmaCorp Rx filed a registration statement on June 1, 2026, providing details about a securities offering with the SEC.

16 hours ago - Filings

PharmaCorp Rx Registration statement: Q1 2026

PharmaCorp Rx filed a registration statement on June 1, 2026, providing details about a securities offering with the SEC.

16 hours ago - Filings

PharmaCorp Rx Earnings release: Q1 2026

PharmaCorp Rx released its Q1 2026 earnings on June 1, 2026, summarizing the period's financial results.

16 hours ago - Filings

PharmaCorp Rx Slides: Investor presentation

PharmaCorp Rx has posted slides in relation to its latest quarterly earnings report, which was published on May 6, 2026.

26 days ago - Filings

PharmaCorp Rx Earnings release: Q4 2025

PharmaCorp Rx released its Q4 2025 earnings on April 29, 2026, summarizing the period's financial results.

4 weeks ago - Filings

PharmaCorp Rx Transcript: 2026 Bloom Burton & Co. Healthcare Investor Conference

At the 2026 Bloom Burton Healthcare Investor Conference, a pharmacy roll-up firm detailed its exclusive acquisition pipeline, flexible exit options for owners, and focus on operational stability and top-line growth. Recent capital raised will fund further expansion and team growth.

5 weeks ago - Transcripts

PharmaCorp Rx Earnings release: Q3 2025

PharmaCorp Rx released its Q3 2025 earnings on November 27, 2025, summarizing the period's financial results.

6 months ago - Filings

PharmaCorp Rx Slides: Q3 2025

PharmaCorp Rx has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on November 27, 2025.

6 months ago - Filings

PharmaCorp Rx Earnings release: Q2 2025

PharmaCorp Rx released its Q2 2025 earnings on August 15, 2025, summarizing the period's financial results.

10 months ago - Filings

PharmaCorp Rx Slides: Q2 2025

PharmaCorp Rx has posted slides in relation to its Q2 2025 quarterly earnings report, which was published on August 15, 2025.

10 months ago - Filings